Formoterol Fumarate(for moh’ te rol)
Foradil Aerolizer, Perforomist
PREGNANCY CATEGORY C
Drug Classes
Antiasthmatic
Beta2 agonist
Therapeutic Actions
Long-acting agonist that binds to beta2 receptors in the lungs, causing bronchodilation; may also inhibit the release of inflammatory mediators in the lung, blocking swelling and inflammation.
Indications
Long-term maintenance treatment of asthma in adults and children 5 yr and older when used in combination with other drugs such as inhaled corticosteroids
Prevention of exercise-induced bronchospasm in adults and children 5 yr and older when used on an occasional, as-needed basis
Long-term maintenance treatment of bronchoconstriction in patients with COPD
Contraindications and Cautions
Contraindicated with hypersensitivity to adrenergics, amines, or formoterol; acute asthma attack; acute airway obstruction; asthma, without concomitant use of other drugs such as inhaled corticosteroids
Use cautiously in the elderly and with pregnancy, lactation.
Available Forms
Inhalation powder in capsules—12 mcg; inhalation solution—20 mcg/2 mL
Dosages
Adults
Maintenance treatment of COPD: Oral inhalation of contents of 1 capsule (12 mcg) using Aerolizer Inhaler every 12 hr; do not exceed a total daily dose of 24 mcg. Or, one 20-mcg/2 mL vial by oral inhalation using a jet nebulizer connected to an air compressor twice daily, morning and evening; do not exceed 40 mcg/day.
Adults and pediatric patients 12 yr and older
Prevention of exercise-induced bronchospasm: Oral inhalation of contents of one capsule (12 mcg) using the Aerolizer Inhaler 15 min before exercise. Additional doses should not be used for 72 hr. Use on an occasional, as-needed basis.
Adults and pediatric patients 5 yr and older
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
